Chlamydia by NAA

Laboratory assay overview

BV (sialidase) activity: Enzyme activity test for use in the detection of vaginal fluid specimens for sialidase activity, an enzyme produced by bacteria associated with bacterial vaginitis, including Bacteroides spp , Prevotella spp , and Mobiluncus spp , and some G vaginalis . In a recent study, Bradshaw et al demonstrated the test to be 88% sensitive and 95% specific. Vaginal yeast culture: Detect yeast in vaginal fluid Chlamydia trachomatis , Neisseria gonorrhoeae , Trichomonas vaginalis by NAA: Diagnosis of C trachomatis , N gonorrhoeae , and T vaginalis infections

Laboratory assay overview

C. trachomatis infections are the leading cause of sexually transmitted diseases in the united states. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of chlamydial infections are severe if left untreated. Approximately half of chlamydial infections are asymptomatic.

Laboratory assay overview

Detect Chlamydia trachomatis

Laboratory assay overview

Diagnosis of Chlamydia trachomatis , Neisseria gonorrhoeae , and Trichomonas vaginalis infections

Laboratory assay overview

Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infections; detect and type active HSV shedding.

Laboratory assay overview

This test is used for diagnosis of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infections, and to detect and type active HSV shedding.

Laboratory assay overview

This test is used to detect Chlamydia trachomatis and Neisseria gonorrhoeae .

Laboratory assay overview

Detect Chlamydia trachomatis and Neisseria gonorrhoeae ( Gonococcus )

Laboratory assay overview

Diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection . If a positive result is obtained for either Chlamydia trachomatis or Neisseria gonorrhoeae , testing for Trichomonas vaginalis is performed.

Laboratory assay overview

Initial screening profile intended for the first prenatal visit to evaluate health status in early pregnancy. This profile aligns with current clinical guidelines and recommendations (see references).

Laboratory assay overview

This initial screening profile is intended for the first prenatal visit to evaluate health status in early pregnancy. This profile aligns with current clinical guidelines and recommendations and includes the HBV triple panel (see references).

Laboratory assay overview

This initial screening profile is intended for the first prenatal visit to evaluate health status in early pregnancy. This profile aligns with current clinical guidelines and recommendations and includes the HBV triple panel, VZV IgG, and QuantiFERON-TB Gold Plus.

Laboratory assay overview

C. trachomatis infections are the leading cause of sexually transmitted diseases in the United States. C. trachomatis is known to cause cervicitis, pelvic inflammatory disease (PID), epididymitis and proctitis. It is also the most frequent cause of non-gonococcal urethritis in men. Among women, the consequences of Chlamydial infections are severe if left untreated. Approximately half of Chlamydial infections are asymptomatic. Neisseria gonorrhoeae (gonococci) is the causative agent of gonorrhea. In men, this disease generally results in anterior urethritis accompanied by purulent exudate. In women, the disease is most often found in the cervix, but the vagina and uterus may also be infected. This assay may be performed as part of an overall screening regimen for patients considering or who are currently taking HIV PrEP. Please refer to the "Preexposure Prophylaxis for the Prevention of HIV Infection in the United States - 2021 Update Clinical Practice Guideline" for additional information.

Quest Diagnostics population reference ranges

Quest Diagnostics calculates these statistical intervals for this specific assay and demographic group, not as universal optimal targets.

Laboratory assay overview

This test is for PrEP use only. Testing includes detection of Chlamydia trachomatis or Neisseria gonorrhoeae in urine or swab specimens.

Laboratory assay overview

This profile aligns with current guidelines for assessment of female patients prior to the initiation of injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; reflexive testing for the detection of HCV infection; and assessment of pregnancy status.

Laboratory assay overview

This profile aligns with current guidelines for monitoring female patients on injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen screen with reflex for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; and assessment of pregnancy status.

Laboratory assay overview

This profile aligns with current guidelines for monitoring female patients on injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; and assessment of pregnancy status.

Laboratory assay overview

This profile aligns with current guidelines for assessment of female patients prior to the initiation of oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; reflexive testing for the detection of HCV infection; assessment of pregnancy status; and assessment of filtering capacity of the kidney (eGFR).

Laboratory assay overview

This profile aligns with current guidelines for monitoring female patients on oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen screen with reflex for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; and assessment of pregnancy status.

Laboratory assay overview

This profile aligns with current guidelines for monitoring female patients on oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; and assessment of pregnancy status.

Laboratory assay overview

This profile aligns with current guidelines for assessment of male patients prior to the initiation of injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; and reflexive testing for the detection of HCV infection.

Laboratory assay overview

This profile aligns with current guidelines for monitoring male patients on injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen screen with reflex for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis.

Laboratory assay overview

This profile aligns with current guidelines for monitoring male patients on injectable HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis.

Laboratory assay overview

This profile aligns with current guidelines for assessment of male patients prior to the initiation of oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis; serological assessment of HBV infection status; reflexive testing for the detection of HCV infection; and assessment of filtering capacity of the kidney (eGFR).

Laboratory assay overview

This profile aligns with current guidelines for monitoring male patients on oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen screen with reflex for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis.

Laboratory assay overview

This profile aligns with current guidelines for monitoring male patients on oral HIV PrEP. The profile includes HIV Antibody/p24 Antigen and HIV-1/2 RNA for the detection of HIV infection; Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid amplification; serologic testing for syphilis.

Laboratory assay overview

This test is used to detect Chlamydia trachomatis and Neisseria gonorrhoeae .

Laboratory assay overview

This test is used to detect Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis and Mycoplasma genitalium .

Laboratory assay overview

This test is used to screen for and diagnose sexually transmitted infections and blood borne pathogens including syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, Chlamydia trachomatis and Neisseria gonorrhoeae. Testing aligns with current guidelines and recommendations.

Laboratory assay overview

This test is used to screen for and diagnose sexually transmitted infections and blood borne pathogens including syphilis, hepatitis B virus (HBV), hepatitis C virus (HCV), HIV, Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis. Testing aligns with current guidelines and recommendations.